Tracy Weber
Tracy Weber is a managing editor at ProPublica. Previously, Weber was a deputy managing editor and senior reporter covering health care issues at ProPublica and, before that, she reported for the Los Angeles Times, the Los Angeles Herald Examiner and the Orange County Register.
Need to Get in Touch?
Tracy Weber is a managing editor at ProPublica, where she helps oversee and maximize projects across the newsroom.
Weber joined the original ProPublica staff as a reporter in 2008 from the Los Angeles Times, where she paired with Charles Ornstein on a series of articles about a troubled hospital that won the Pulitzer Prize for public service in 2005, among other awards. At ProPublica, she and Ornstein were finalists for the same award in 2010 for a series on the broken oversight of nurses
Weber joined ProPublica’s editing ranks in 2014. In the six years that followed, work she edited won virtually every significant honor in journalism. Among other standouts, this includes a series she co-edited on grave, systemic problems in the Navy that won the 2020 Pulitzer Prize for national reporting; reporting on family separations, which won the Peabody Award’s first ever Catalyst Award, a George Polk award and was a Pulitzer finalist; and a series on jailhouse informants that won a National Magazine Award. She also guided hallmark series on how the financial system punishes the working poor; the gutting of the workers’ comp system; the toxic effect of blood spatter forensics on the justice system; and the rampant waste and perverse incentives in health care.
Doctors Avoid Penalties in Suits Against Medical Firms
At least 15 drug and medical-device companies have paid $6.5 billion since 2008 to settle accusations of marketing fraud or kickbacks, but none of the more than 75 doctors named as participants were sanctioned.
Troubled Health-Care Staffing Chain Settles With Government for $150 Million
Maxim Healthcare Services, Inc. had been accused of submitting false bills to federal and state health programs. An earlier ProPublica investigation found that the company had hired several nurses despite a history of problems.
News Reports Cite Drop in Physician Speaking Fees
Regional newspapers that analyzed ProPublica's Dollars for Docs data say drug company payments to physician speakers have declined in their states, suggesting that new restrictions and publicity are making an impact.
Patients Deserve to Know What Drug Companies Pay Their Doctor
ProPublica's newly updated Dollars for Docs database offers a glimpse of what patients can expect in 2013, when all drug and medical-device companies must report to the federal government what they pay doctors to help market their products.
Piercing the Veil, More Drug Companies Reveal Payments to Doctors
An update of ProPublica's Dollars for Docs database includes more than $760 million in payments from 12 pharmaceutical companies to physicians and other health-care providers for consulting, speaking, research and expenses.
With Our Dollars for Docs Update Coming, Drug Companies Defend 'Interactions' With Physicians
As ProPublica gets ready to refresh its Dollars for Docs database listing payments from drug companies to hundreds of thousands of doctors, the Pharmaceutical Research and Manufacturers of America says paid physician speakers play a critical role in improving patient care.
Medical Schools Plug Holes in Conflict-of-Interest Policies
Reacting to ProPublica's Dollars for Docs coverage, Stanford and other schools discipline doctors, rewrite policies and increase scrutiny of drug-industry ties.
How Much Money Do Groups Receive From Industry?
In a response to a request from Sen. Charles Grassley, R-Iowa, 33 professional associations and health advocacy groups listed their payments from the pharmaceutical, medical device and insurance industries. They also detailed the relationships that the groups’ executives and board members had with the same companies.
Heart Society’s Tip Sheets Fail To Mention Risks
The Heart Rhythm Society says the financial support it receives from drug and medical-device makers plays no role in its advocacy for certain treatments. Information sheets published by the group do not mention potential risks from implanted defibrillators or cardiac catheter ablation.